Related Experiment Video
Updated: Aug 4, 2026
10:02
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
Alpha-adrenergic receptors in rabbit eyes
1Department of Ophthalmology, California College of Medicine, University of California, Irvine.
Journal of Ocular Pharmacology
|January 1, 1985
Summary
Alpha-adrenergic agonists increase intraocular pressure (IOP) and pupil size in rabbits. These effects are mediated by specific alpha-receptor subtypes, suggesting novel therapeutic targets for ocular conditions.
Area of Science:
- Ophthalmology
- Pharmacology
- Neuroscience
Background:
- Alpha-adrenergic receptors play a role in regulating intraocular pressure (IOP) and pupil diameter.
- Understanding the specific subtypes involved is crucial for developing targeted ocular therapies.
Purpose of the Study:
- To investigate the roles of alpha-1 and alpha-2 adrenergic receptors in mediating IOP and pupil responses to agonists and blockers in albino rabbits.
- To differentiate the receptor subtypes responsible for early IOP elevation versus mydriasis.
Main Methods:
- Topical ocular administration of alpha-adrenergic agonists (methoxamine, oxymetazoline, clonidine) and blockers (prazosin, yohimbine, phentolamine) in albino rabbits.
- Measurement of intraocular pressure (IOP) and pupil diameter.
- Comparison of responses in normal versus surgically sympathectomized rabbits.
Main Results:
- Alpha-1 and alpha-2 agonists caused dose-related increases in IOP, inhibited by alpha-1 and alpha-2 blockers, respectively.
- The mydriatic response to agonists was blocked by a nonselective alpha-blocker but not by selective alpha-1 or alpha-2 blockers.
- Sympathectomy reduced hypersensitivity to agonists, with ipsilateral eyes showing greater IOP increase than contralateral eyes.
Conclusions:
- The early IOP rise induced by alpha-agonists is primarily mediated by postsynaptic alpha-1 receptors, potentially on ocular blood vessels.
- The mydriatic effect appears to involve alpha-receptors distinct from classical alpha-1 and alpha-2 subtypes.
- Findings suggest distinct receptor populations mediate IOP and pupillary responses to alpha-adrenergic stimulation.
Related Concept Videos
01:27Adrenergic Receptors (Adrenoceptors): Classification
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
01:31Adrenergic Receptors: ɑ Subtype
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
01:26Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
01:17Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
01:22Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...